Effect of Vitamin D Supplementation on Psoriasis Severity in Patients With Lower-Range Serum 25-Hydroxyvitamin D Levels: A Randomized Clinical Trial.

Jenssen M, Furberg AS, Jorde R, Wilsgaard T, Danielsen K

Open source

DOI
10.1001/jamadermatol.2023.0357
Published
2023 May 1
Container
JAMA dermatology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jamadermatol.2023.0357,
  title = {Effect of Vitamin D Supplementation on Psoriasis Severity in Patients With Lower-Range Serum 25-Hydroxyvitamin D Levels: A Randomized Clinical Trial.},
  author = {Jenssen M and Furberg AS and Jorde R and Wilsgaard T and Danielsen K},
  year = {2023},
  journal = {JAMA dermatology},
  doi = {10.1001/jamadermatol.2023.0357},
  url = {https://doi.org/10.1001/jamadermatol.2023.0357}
}

RIS

TY  - JOUR
TI  - Effect of Vitamin D Supplementation on Psoriasis Severity in Patients With Lower-Range Serum 25-Hydroxyvitamin D Levels: A Randomized Clinical Trial.
AU  - Jenssen M
AU  - Furberg AS
AU  - Jorde R
AU  - Wilsgaard T
AU  - Danielsen K
PY  - 2023
JO  - JAMA dermatology
DO  - 10.1001/jamadermatol.2023.0357
UR  - https://doi.org/10.1001/jamadermatol.2023.0357
ER  - 

APA

M, J., AS, F., R, J., T, W., & K, D. (2023). Effect of Vitamin D Supplementation on Psoriasis Severity in Patients With Lower-Range Serum 25-Hydroxyvitamin D Levels: A Randomized Clinical Trial.. JAMA dermatology. https://doi.org/10.1001/jamadermatol.2023.0357

Source records